Product Details
Product Details
Product Specification
| Host | Rat |
| Antigen | CD163 |
| Location | Membrane |
| Accession | B7ZMW6 |
| Clone Number | S-R608 |
| Antibody Type | Rat mAb |
| Isotype | IgG2a,k |
| Application | FCM |
| Reactivity | Ms |
| Purification | Protein G |
| Conjugation | Alexa Fluor® 647 |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 5 μl per million cells in 100μl volume |
Background
CD163 is a 130 kDa type I transmembrane glycoprotein and a member of the scavenger receptor cysteine-rich (SRCR) superfamily. It is exclusively expressed on monocytes and macrophages and is involved in the clearance and endocytosis of hemoglobin-haptoglobin complexes, which helps protect tissues from oxidative damage caused by free hemoglobin. The protein consists of nine SRCR domains, a single transmembrane segment, and a short cytoplasmic tail. CD163 is upregulated in macrophages during the switch to alternative activated phenotypes in inflammation and is considered a marker for anti-inflammatory macrophages. Elevated levels of soluble CD163, which result from the shedding of the membrane-bound form, have been observed in various acute and chronic inflammatory disorders, making it a potential biomarker for inflammation. Additionally, CD163 is being explored as a therapeutic target for delivering drugs to macrophages in inflammatory conditions.
